Boston Sci Stent Development Proceeding In-House; J&J Velocity Moves Fast

Boston Scientific is pursuing the development of its next-generation coronary stent platform internally as well as with partner Medinol as a contingency to the ongoing uncertainties with the Israeli firm.

More from Archive

More from Medtech Insight